De-Novo B-Cell Prolymphocytic Leukemia.
Menakuru SR, Roepke J, Siddiqui S.
J Hematol. 2023 Apr;12(2):82-86. doi: 10.14740/jh1096. Epub 2023 Apr 30.
B-cell prolymphocytic leukemia after COVID-19 infection.
Falini B, Lazzi S.
Blood. 2023 Apr 6;141(14):1777. doi: 10.1182/blood.2023019816.
B-cell prolymphocytic leukemia has 3 subsets.
Kay NE, Hanson CA.
Blood. 2019 Nov 21;134(21):1777-1778. doi: 10.1182/blood.2019003046.
Lymphoproliferative Disorders.
Justiz Vaillant AA, Stang CM.
2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
B and T cell prolymphocytic leukaemia.
Cross M, Dearden C.
Best Pract Res Clin Haematol. 2019 Sep;32(3):217-228. doi: 10.1016/j.beha.2019.06.001. Epub 2019 Jun 6.
An illustrative case of B-cell prolymphocytic leukemia.
Jain A, Khunger JM, Prasad P, Chaudhry S, Sharma M, Gupta DK, Saluja S.
Blood Res. 2020 Sep 30;55(3):181-184. doi: 10.5045/br.2020.2020079.
Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
Czader M, Amador C, Cook JR, Thakkar D, Parker C, Dave SS, Dogan A, Duffield AS, Nejati R, Ott G, Xiao W, Wasik M, Goodlad JR.
Am J Clin Pathol. 2023 Jun 1;159(6):554-571. doi: 10.1093/ajcp/aqad027.
B-prolymphocytic leukemia: Is it time to retire this entity?
El Hussein S, Khoury JD, Medeiros LJ.
Ann Diagn Pathol. 2021 Oct;54:151790. doi: 10.1016/j.anndiagpath.2021.151790. Epub 2021 Jul 16.
B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases.
Wang A, Guo W, Damiani D, Sumbly V, Goyal G, Du Z, Bai O.
Transl Cancer Res. 2023 Jul 31;12(7):1873-1882. doi: 10.21037/tcr-23-828. Epub 2023 Jul 20.
PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.
Nachat A, Turoff-Ortmeyer S, Liu C, Mcculloch M.
Perm J. 2016 Spring;20(2):74-80. doi: 10.7812/TPP/15-153.
